Zhongyuan Union Stem Cell Bioengineering Co., Ltd. at its directorate meeting on September 21, 2012, approved the proposal of appointing Wu Hanxu as CFO.
Vcanbio Cell & Gene Engineering Corp., Ltd
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.43 CNY | -0.11% | -1.80% | -14.01% |
1st Jan change | Capi. | |
---|---|---|
-14.01% | 1.11B | |
-3.43% | 12.45B | |
-3.17% | 8.22B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B | |
-7.56% | 1.8B |
- Stock Market
- Equities
- 600645 Stock
- News Vcanbio Cell & Gene Engineering Corp., Ltd
- Zhongyuan Union Stem Cell Bioengineering Co., Ltd. Approves to Appoint Wu Hanxu as CFO